Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Net Income towards Common Stockholders (2017 - 2025)

Historic Net Income towards Common Stockholders for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $136.1 million.

  • Inspire Medical Systems' Net Income towards Common Stockholders rose 28635.59% to $136.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $145.3 million, marking a year-over-year increase of 17212.8%. This contributed to the annual value of $145.4 million for FY2025, which is 17177.11% up from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Net Income towards Common Stockholders is $136.1 million, which was up 28635.59% from $9.9 million recorded in Q3 2025.
  • Inspire Medical Systems' Net Income towards Common Stockholders' 5-year high stood at $136.1 million during Q4 2025, with a 5-year trough of -$16.8 million in Q3 2022.
  • Its 5-year average for Net Income towards Common Stockholders is $4.5 million, with a median of -$6.1 million in 2023.
  • In the last 5 years, Inspire Medical Systems' Net Income towards Common Stockholders surged by 36783.68% in 2023 and then tumbled by 13726.66% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Net Income towards Common Stockholders stood at -$2.3 million in 2021, then surged by 234.96% to $3.2 million in 2022, then soared by 367.84% to $14.8 million in 2023, then surged by 138.11% to $35.2 million in 2024, then surged by 286.36% to $136.1 million in 2025.
  • Its Net Income towards Common Stockholders was $136.1 million in Q4 2025, compared to $9.9 million in Q3 2025 and -$3.6 million in Q2 2025.